Literature DB >> 178822

A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus.

N Rosenberg, D Baltimore.   

Abstract

A quantitative Abelson murine leukemia virus (A-MuLV) lymphoid cell transformation assay has been developed using a semisolid agarose culture system. Under these conditions lymphoid cell transformation was shown to vary linearly with the dose of A-MuLV used. The susceptibility of bone marrow cells from different strains of mice to A-MuLV-induced transformation can be estimated using the agarose assay. Strains with bone marrow cells of high, medium, and low susceptibility to A-MuLV can be identified. The assay has been used to study the susceptibility of cells from lymphoid organs of fetal and adult mice to A-MuLV. Cell suspensions from fetal liver, adult bone marrow, and adult spleen are susceptible to A-MuLV, while thymocytes are resistant to A-MuLV-induced transformation. Bovine serum albumin gradient fractionation of bone marrow cells before infection with A-MuLV demonstrates that the majority of A-MuLV-sensitive cells are recovered in a broad band partially overlapping the majority of the nucleated cells. The agarose assay system allows study of A-MuLV-lymphoid cell interaction at the level of single cell-single virus particle interaction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178822      PMCID: PMC2190217          DOI: 10.1084/jem.143.6.1453

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

Review 1.  B-lymphocyte subpopulations in the mouse. Organ distribution and ontogeny of immunoglobulin-synthesizing and of mitogen-sensitive cells.

Authors:  F Melchers; H Von Boehmer; R A Phillips
Journal:  Transplant Rev       Date:  1975

2.  AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS.

Authors:  I MACPHERSON; L MONTAGNIER
Journal:  Virology       Date:  1964-06       Impact factor: 3.616

3.  Growth of B lymphocyte colonies in vitro from mouse lymphoid organs.

Authors:  D Metcalf; N L Warner; G J Nossal; J F Miller; K Shortman; E Rabellino
Journal:  Nature       Date:  1975-06-19       Impact factor: 49.962

4.  Transplantation and preliminary characterisation of lymphocyte surface markers of Abelson virus-induced lymphomas.

Authors:  M D Sklar; E M Shevach; I Green; M Potter
Journal:  Nature       Date:  1975-02-13       Impact factor: 49.962

5.  Direct transformation of 3T3 cells by Abelson murine leukaemia virus.

Authors:  C D Scher; R Siegler
Journal:  Nature       Date:  1975-02-27       Impact factor: 49.962

6.  In vitro transformation of lymphoid cells by Abelson murine leukemia virus.

Authors:  N Rosenberg; D Baltimore; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

7.  Synthesis, surface deposition, and secretion of immunoglobulins by Abelson virus-transformed lymphosarcoma cell lines.

Authors:  E Premkumar; M Potter; P A Singer; M D Sklar
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

8.  Oncogenic transformation of murine lymphoid cells by in vitro infection with Abelson leukemia virus.

Authors:  W C Raschke; P Ralph; J Watson; M Sklar; H Coon
Journal:  J Natl Cancer Inst       Date:  1975-05       Impact factor: 13.506

9.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

10.  Murine terminal deoxynucleotidyl transferase: cellular distribution and response to cortisone.

Authors:  P C Kung; A E Siverstone; R P McCaffrey; D Baltimore
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

View more
  123 in total

1.  Functional characterization of B lymphocytes generated in vitro from embryonic stem cells.

Authors:  S K Cho; T D Webber; J R Carlyle; T Nakano; S M Lewis; J C Zúñiga-Pflücker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Postcleavage sequence specificity in V(D)J recombination.

Authors:  E A Agard; S M Lewis
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

3.  Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

Authors:  S Mai; J Hanley-Hyde; G J Rainey; T I Kuschak; J T Paul; T D Littlewood; H Mischak; L M Stevens; D W Henderson; J F Mushinski
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

4.  Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.

Authors:  K C Thome; A Radfar; N Rosenberg
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.

Authors:  Chae-Ryun Yi; Naomi Rosenberg
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

6.  A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-beta) gene regulation.

Authors:  S J Fashena; R Reeves; N H Ruddle
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

7.  Involvement of wild-type p53 in pre-B-cell differentiation in vitro.

Authors:  G Shaulsky; N Goldfinger; A Peled; V Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

8.  Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program.

Authors:  B Weissman; S A Aaronson
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

9.  Rapid thymomas induced by Abelson murine leukemia virus.

Authors:  W D Cook
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

10.  Hematopoietic cell transformation by a murine recombinant retrovirus containing the src gene of Rous sarcoma virus.

Authors:  J H Pierce; S A Aaronson; S M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.